Lavipharm

Lavipharm EBITDA per Share

The EBITDA per Share of Lavipharm (LAVI.AT) as of Oct 11, 2026 is 0.05 EUR. In the previous year, EBITDA per Share was 0.04 EUR — a change of 32.07% (higher).

EBITDA per Share

0.05EUR

YoY

32.07%

Last updated:

EBITDA per Share of Lavipharm is 2025 0.05 EUR. EBITDA per Share of Lavipharm was 2024 0.04 EUR. It decreases by 32.07% higher compared to the previous year.

The Lavipharm EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.03 EUR
Jan 1, 2019
0.03 EUR
Jan 1, 2020
0.04 EUR
Jan 1, 2021
0.04 EUR
Jan 1, 2022
0.02 EUR
Jan 1, 2023
0.03 EUR
Jan 1, 2024
0.04 EUR
Jan 1, 2025
0.05 EUR
The Lavipharm EBITDA per Share history
YEAREBITDA per ShareYoY
0.05EUR+32.07%
0.04EUR+20.77%
0.03EUR+46.90%
0.02EUR-41.56%
0.04EUR+2.83%
0.04EUR+27.48%
0.03EUR-13.82%
0.03EUR-64.55%
0.10EUR+127.35%
0.04EUR+233.92%
0.01EUR-123.84%
-0.05EUR—
Access this data via the Eulerpool API
Get Free API Key

Lavipharm Stock analysis

What does Lavipharm do? Lavipharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lavipharm stock

EBITDA per Share of Lavipharm is 0.05 EUR in 2025.

EBITDA per Share of Lavipharm changed from 0.04 EUR to 0.05 EUR, representing a 32.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Lavipharm since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Lavipharm

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Lavipharm